0001683168-23-003269.txt : 20230512 0001683168-23-003269.hdr.sgml : 20230512 20230512163108 ACCESSION NUMBER: 0001683168-23-003269 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeoVolta Inc. CENTRAL INDEX KEY: 0001748137 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 825299263 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41447 FILM NUMBER: 23916344 BUSINESS ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 BUSINESS PHONE: 800-364-5464 MAIL ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta, Inc. DATE OF NAME CHANGE: 20220613 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta Inc. DATE OF NAME CHANGE: 20180725 10-Q 1 neovolta_i10q-033123.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended March 31, 2023

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ______________

Commission File Number: 001-41447

NeoVolta, Inc.

(Exact name of registrant as specified in its charter)

Nevada

82-5299263

(State or other jurisdiction

of incorporation)

(I.R.S. Employer

Identification No.)

13651 Danielson Street, Suite A

Poway, CA

92064

(Address of principal

executive offices)

(zip code)

Registrant’s telephone number, including area code: (800) 364-5464

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol (s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	NEOV	The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock	NEOVW	The NASDAQ Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒ No: ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒ No: ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐		Accelerated filer ☐
Non-accelerated filer ☒		Smaller reporting company ☒
		Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

The number of shares outstanding of Common Stock, par value $0.001 per share, as of May 12, 2023, was 33,155,127 shares.

NEOVOLTA, INC.

FORM 10-Q

MARCH 31, 2023

INDEX

	Page
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements	4
Balance Sheets as of March 31, 2023 (Unaudited) and June 30, 2022	4
Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited)	5
Statements of Operations for the nine months ended March 31, 2023 and 2022 (Unaudited)	6
Statements of Stockholders’ Equity for the nine months ended March 31, 2023 and 2022 (Unaudited)	7
Statements of Cash Flows for the nine months ended March 31, 2023 and 2022 (Unaudited)	8
Notes to Financial Statements (Unaudited)	9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3. Quantitative and Qualitative Disclosures About Market Risk	20
Item 4. Controls and Procedures	20

PART II. OTHER INFORMATION

Item 1. Legal Proceedings	21
Item 1A. Risk Factors	21
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	21
Item 3. Defaults Upon Senior Securities	22
Item 4. Mine Safety Disclosures	22
Item 5. Other Information	22
Item 6. Exhibits	22
Signatures	23

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report.

You should read the matters described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

All forward-looking statements speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.

PART I . FINANCIAL INFORMATION

ITEM 1.

Financial Statements

NEOVOLTA, INC.

Balance Sheets


	March 31,			June 30,
	2023			2022
	(Unaudited)

Assets
Current assets:
Cash and cash equivalents	$	3,460,190		$	330,385
Accounts receivable, net		1,737,651			1,317,738
Inventory		1,362,289			2,238,208
Prepaid insurance and other current assets		205,710			239,001
Total current assets		6,765,840			4,125,332

Total assets	$	6,765,840		$	4,125,332

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	–		$	205,600
Accrued interest payable		–			53,436
Other accrued liabilities		87,651			127,356
Convertible notes payable		–			1,068,000
Total current liabilities		87,651			1,454,392

Convertible notes payable		–			53,716
Total liabilities		87,651			1,508,108

Commitments and contingencies (Note 4)		–			–

Stockholders' equity:
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,155,127 and 21,977,251 shares issued and outstanding		33,155			21,978
Additional paid-in capital		24,763,356			18,394,641
Accumulated deficit		(18,118,322	)		(15,799,395	)
Total stockholders' equity		6,678,189			2,617,224

Total liabilities and stockholders' equity	$	6,765,840		$	4,125,332

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Operations

(Unaudited)


	Three Months Ended
	March 31,
	2023			2022

Revenues from contracts with customers	$	629,010		$	932,903
Cost of goods sold		537,261			810,563
Gross profit		91,749			122,340

Operating expenses:
General and administrative		723,271			620,214
Research and development		1,290			–
Total operating expenses		724,561			620,214

Loss from operations		(632,812	)		(497,874	)

Other income (expense):
Interest expense		–			(21,829	)
Total other income (expense)		–			(21,829	)

Net loss	$	(632,812	)	$	(519,703	)

Weighted average shares outstanding - basic and diluted		33,151,685			20,287,634

Net loss per share - basic and diluted	$	(0.02	)	$	(0.03	)

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Operations

(Unaudited)


	Nine Months Ended
	March 31,
	2023			2022

Revenues from contracts with customers	$	2,733,951		$	3,567,634
Cost of goods sold		2,302,380			3,033,263
Gross profit		431,571			534,371

Operating expenses:
General and administrative		2,716,428			5,114,267
Research and development		29,936			66,503
Total operating expenses		2,746,364			5,180,770

Loss from operations		(2,314,793	)		(4,646,399	)

Other income (expense):
Interest expense		(4,134	)		(31,365	)
Total other income (expense)		(4,134	)		(31,365	)

Net loss	$	(2,318,927	)	$	(4,677,764	)

Weighted average shares outstanding - basic and diluted		31,650,491			20,082,627

Net loss per share - basic and diluted	$	(0.07	)	$	(0.23	)

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Stockholders' Equity

Nine Months Ended March 31, 2023 and 2022

(Unaudited)


					Additional					Total
	Common Stock				Paid-in		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Equity

Balance at June 30, 2022		21,977,251	$	21,978	$	18,394,641	$	(15,799,395	)	$	2,617,224
Issuance of common stock in underwritten public offering		1,121,250		1,121		3,779,284		–			3,780,405
Issuance of common stock for conversion of debt and accrued interest		9,671,867		9,672		1,169,614		–			1,179,286
Stock compensation expense		–		–		591,816		–			591,816
Net loss		–		–		–		(698,586	)		(698,586	)

Balance at September 30, 2022		32,770,368		32,771		23,935,355		(16,497,981	)		7,470,145
Stock compensation expense		75,000		75		719,220		–			719,295
Net loss		–		–		–		(987,529	)		(987,529	)

Balance at December 31, 2022		32,845,368		32,846		24,654,575		(17,485,510	)		7,201,911
Stock compensation expense		309,759		309		108,781		–			109,090
Net loss		–		–		–		(632,812	)		(632,812	)

Balance at March 31, 2023		33,155,127	$	33,155	$	24,763,356	$	(18,118,322	)	$	6,678,189

					Additional						Total
	Common Stock				Paid-in			Accumulated			Stockholders'
	Shares		Amount		Capital			Deficit			Equity

Balance at June 30, 2021		19,640,888	$	19,641	$	13,169,363		$	(10,040,370	)	$	3,148,634
Issuance of common stock for conversion of debt and accrued interest		203,630		204		1,079			–			1,283
Stock compensation expense		154,165		154		130,469			–			130,623
Adjustment for change in accounting principle		–		–		(87,116	)		45,809			(41,307	)
Net loss		–		–		–			(128,207	)		(128,207	)

Balance at September 30, 2021		19,998,683		19,999		13,213,795			(10,122,768	)		3,111,026
Stock compensation expense		–		–		3,870,935			–			3,870,935
Net loss		–		–		–			(4,029,854	)		(4,029,854	)

Balance at December 31, 2021		19,998,683		19,999		17,084,730			(14,152,622	)		2,952,107
Issuance of common stock for conversion of debt and accrued interest		895,000		895		4,744			–			5,639
Stock compensation expense		1,083,568		1,084		358,728			–			359,812
Net loss		–		–		–			(519,703	)		(519,703	)

Balance at March 31, 2022		21,977,251	$	21,978	$	17,448,202		$	(14,672,325	)	$	2,797,855

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Statements of Cash Flows

(Unaudited)


	Nine Months Ended
	March 31,
	2023			2022

Cash flows from operating activities:
Net loss	$	(2,318,927	)	$	(4,677,764	)
Adjustments to reconcile net loss to net cash used in operations:
Stock compensation expense		1,420,201			4,361,370
Bad debt expense		380,000			–
Changes in current assets and liabilities
Accounts receivable		(799,913	)		(232,921	)
Inventory		875,919			(15,481	)
Prepaid insurance and other current assets		33,291			(119,086	)
Accounts payable		(205,600	)		(49,343	)
Accrued expenses		(35,571	)		25,533
Net cash flows used in operating activities		(650,600	)		(707,692	)

Cash flows from financing activities:
Underwritten public offering of common stock		3,780,405			–
Proceeds from convertible notes payable		–			1,068,000
Net cash flows provided by financing activities		3,780,405			1,068,000

Net increase in cash and cash equivalents		3,129,805			360,308

Cash and cash equivalents at beginning of period		330,385			425,681

Cash and cash equivalents at end of period	$	3,460,190		$	785,989

Supplemental disclosures of cash flow information
Cash paid for interest	$	–		$	–
Cash paid for income taxes	$	–		$	–

Supplemental non-cash financing activities
Conversion of convertible debt and accrued interest into common stock	$	1,179,286		$	6,922
Adjustment of debt discount related to adoption of new accounting principle	$	–		$	87,116

See accompanying notes to unaudited financial statements.

NEOVOLTA, INC.

Notes to Financial Statements

(Unaudited)

(1) Business and Summary of Significant Accounting Policies

Description of Business – NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2023, the results of its operations for the three and nine month periods ended March 31, 2023 and 2022, the changes in its stockholders’ equity for the nine month periods ended March 31, 2023 and 2022, and cash flows for the nine month periods ended March 31, 2023 and 2022. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2023, the Company maintained accounts at two different banks, of which the balance at the first bank was within the FDIC insurance limit while the balance at the second bank was in excess of the FDIC insurance limit by $3,028,474.

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of March 31, 2023 and June 30, 2022:

Schedule of inventory
	March 31,		June 30,
	2023		2022

Raw materials	$	1,299,494	$	1,844,049
Work in process		62,795		22,768
Finished goods		–		371,391

Total	$	1,362,289	$	2,238,208

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2023 and June 30, 2022.

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 21%, 18% and 16% of the Company’s revenues in the nine months ended March 31, 2023, however, no other dealers accounted for more than 10% of the revenues in such period. Those same three dealers represented an aggregate of approximately 83% of the Company’s accounts receivable as of March 31, 2023 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of March 31, 2023. Two dealers represented approximately 22%, and 16% of the Company’s revenues in the nine months ended March 31, 2022. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2023 and 2022 is provided.

Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2023 and June 30, 2022, our allowance for doubtful accounts was $380,000 and zero, respectively.

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2023, the Company had total outstanding common stock equivalents of 1,229,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) 50,000 shares related to restricted stock units granted to an officer in March 2022 (see Note 3).

Research and Development Costs – Research and development costs are expensed as incurred.

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 - Inputs that are both significant to the fair value measurement and unobservable. The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.

At March 31, 2023 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

(2) Notes Payable

In conjunction with the closing of our underwritten public offering in August 2022 (see Note 3), all holders of the Company’s two outstanding series of convertible notes payable, which were originally issued to various accredited investors in May 2018 and October 2021, agreed to convert their debt into a total of 9,671,867 shares of our common stock at the respective conversion rates. Each of these two series of our converted notes payable is further described below.

In May 2018, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $104,688. Each unsecured note originally bore interest at a rate of 12% per annum, which was later reduced by mutual agreement to 3.99% per annum in May 2019. Subsequently, the holders of certain of these notes elected to convert or exchange certain portions of their convertible notes payable into shares of our common stock, based upon the stated conversion rate of $0.0063 per share. As of the closing of our underwritten public offering in August 2022, the holders of the remaining balance of such unconverted notes in the total amount of $59,251, including accrued interest, agreed to convert their debt into a total of 9,404,867 shares of our common stock at the stated conversion rate of $0.0063 per share.

In October 2021, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $1,068,000. Each unsecured note bore interest at a rate of 6% per annum. As of the closing of our underwritten public offering in August 2022, pursuant to the terms of such convertible notes, the notes were automatically converted into a total of 267,000 shares of our common stock at the stated conversion rate of $4.00 of principal per share.

(3) Equity

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate (see Note 2).

In the nine months ended March 31, 2022, the holders of the 2018 convertible notes payable having total principal and accrued interest balances in the aggregate amount of $6,922 elected to convert their notes. Based upon the stated conversion price of $0.0063 per share, these holders converted their notes payable into a total of 1,098,630 shares of common stock (see Note 2).

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

The following table presents activity with respect to the Company’s warrants for the nine months ended March 31, 2023:

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at July 1, 2022

–

Warrants issued to Public Investors

1,121,250

4.00

–

Warrants issued to Underwriters

58,500

4.40

–

Outstanding at March 31, 2023

1,179,750

4.02

4.3

–

Exercisable at March 31, 2023

1,179,750

4.02

4.3

–

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement was one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of January 1, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to the CEO as of that date.

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to the CFO as of that date.

Based upon the Company’s assessment of the probability of the CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, the Company has calculated the grant date value of such awards and is amortizing it as stock compensation expense over the underlying performance periods. The Company has recognized stock compensation expense applicable to such RSU awards in the nine months ended March 31, 2023 in the amount of $1,200,723.

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of March 31, 2023, we booked an initial accrual of $146,250 of compensation expense (of which $131,625 will be settled through the issuance of shares) for our three independent directors under this plan. At the same time, we also granted 26,000 shares, with a grant date value of $97,500, to various advisors pursuant to annual contracts for their services.

In the nine months ended March 31, 2023, we recognized total non-cash stock compensation expense of $1,420,201 as follows: (i) $1,200,723 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $60,625 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $27,228 for the fair value of incentive shares earned by two wholesale dealers as of December 31, 2022 (see Note 4). There was a total of 384,759 shares of common stock that were issued to various grantees, including our two executive officers, in the nine months ended March 31, 2023, of which 75,000 shares were previously expensed in the year ended June 30, 2022.

In the nine months ended March 31, 2022, we recognized total non-cash stock compensation expense of $4,361,370 as follows: (i) $3,505,000 for the fair value of 500,000 incentive shares earned as of December 31, 2021 by a company controlled by the Company’s CEO under a previous compensation plan (which were not issued until early 2022); (ii) $193,314 for the initial amortized value of the RSUs granted to our two executive officers, as previously described; (iii) $175,250 for the fair value of 25,000 bonus shares earned as of December 31, 2021 by an outside attorney (which were not issued until early 2022); (iv) $236,619 for the amortized value of 50,000 shares granted to an attorney and a consultant pursuant to one year service agreements in mid 2021; (v) $191,125 for the amortized value of 50,000 shares attributable to a new independent director in early 2021; and (vi) $60,062 for the fair value of 8,568 incentive shares earned by a wholesale dealer as of December 31, 2021 (see Note 4). There was a total of 1,237,733 shares of common stock that were issued to various grantees, primarily advisors, attorneys and consultants, in the nine months ended March 31, 2022.

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March 31, 2023, the Company has made awards totaling 450,000 shares for the RSUs granted to two executives, as noted above, under the Plan.

(4) Commitments and Contingencies

Effective January 1, 2021, the Company secured new corporate and manufacturing office space under a sublease agreement with its contract manufacturer. Under the terms of the sublease agreement, the Company is required to make rental payments of $10,350 per month during the initial one-year term of the agreement. The sublease agreement is renewable upon mutual agreement of both parties for up to four additional years at a modest increase in the monthly rent, however, the Company is under no obligation to renew it. Management has determined that the exercise of the renewal option is not reasonably certain and, as such, the Company has accounted for it as a short-term lease under ASC 842, Leases. Effective January 1, 2023, the Company elected to renew the agreement for another one year period (see Note 5).

As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums.

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

(5) Subsequent Events

In April 2023, we amended the agreement with our contract manufacturer (see Note 4) to provide for the purchase by us of all of the contract manufacturer’s existing inventory used to assemble our ESS units and to also provide for the eventual assumption by us of full responsibility for the manufacturing of our ESS units. Pursuant to the amended agreement, we completed the purchase of our contract manufacturer’s assembly inventory by making a cash payment of $1.3 million to this company and have now recorded such purchased inventory on our balance sheet. We presently expect to assume full responsibility for the manufacturing process surrounding our ESS units from the contract manufacturer by June 1, 2023. All of our manufacturing certifications are listed under NeoVolta. This amended agreement has no effect on the present sublease agreement with our contract manufacturer.

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Introduction

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2022, filed with the Securities and Exchange Commission on September 27, 2022 (the “Annual Report”).

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

In addition, unless the context otherwise requires and for the purposes of this Report only:

“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;

“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and

“Securities Act” refers to the Securities Act of 1933, as amended.

Overview

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14 and NV 24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all of our current resources and efforts go into further developing our flagship NV14 and NV 24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we have used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Nevada, Georgia, Utah, Florida, Puerto Rico, Oklahoma, Texas, Colorado, Wyoming, Tennessee, and Missouri.

As further discussed below under “Underwritten Public Offering,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

Underwritten Public Offering

In early August 2022, we completed an underwritten public offering of our equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market under the symbols “NEOV” and “NEOVW,” respectively. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

Between the initial closing of the offering and the underwriters’ exercise of the overallotment option, we sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering, including the underwriters’ exercise of the overallotment option, were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

Results of Operations

The following discussion reflects the Company’s revenues and expenses for the three and nine month periods ended March 31, 2023 and 2022, as reported in our financial statements included in Item 1.

Three months ended March 31, 2023 versus three months ended March 31, 2022

Revenues - Revenues from contracts with customers for the three months ended March 31, 2023 were $629,010 compared to $932,903 for the three months ended March 31, 2022. Such decrease was primarily due to the pendency of the April 2023 effective date of new utility regulations in the State of California that we believe caused an economic disincentive for residential utility customers to acquire our energy storage systems prior to the effective date of those regulations (see “Item 1A. Risk Factors” for a discussion of the new utility regulations).

Cost of Goods Sold - Cost of goods sold for the three months ended March 31, 2023 were $537,261 compared to $810,563 for the three months ended March 31, 2022. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 15% and 13%, respectively.

General and Administrative Expense - General and administrative expenses for the three months ended March 31, 2023 were $723,271 compared to $620,214 for the three months ended March 31, 2022. Such increase was due to the recognition of an allowance for bad debts of $380,000, partially offset by a decrease in stock compensation expense related the Company’s equity incentive programs.

Research and Development Expense - Research and development expenses for the three months ended March 31, 2023 were $1,290 compared to zero for the three months ended March 31, 2022. Such fluctuation was due to a modest increase in the level of the Company’s recent product development efforts.

Interest Expense - Interest expense for the three months ended March 31, 2023 was zero compared to $21,829 for the three months ended March 31, 2022. This decrease resulted from the conversion of our 2018 and 2021 convertible notes in conjunction with the closing of our public equity offering in August 2022.

Net Loss - Net loss for the three months ended March 31, 2023 was $632,812 compared to $519,703 for the three months ended March 31, 2022, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

Nine months ended March 31, 2023 versus nine months ended March 31, 2022

Revenues - Revenues from contracts with customers for the nine months ended March 31, 2023 were $2,733,951 compared to $3,567,634 for the nine months ended March 31, 2022. Such decrease was primarily due to the pendency of the April 2023 effective date of new utility regulations in the State of California that we believe caused an economic disincentive for residential utility customers to acquire our energy storage systems prior to the effective date of those regulations (see “Item 1A. Risk Factors” for a discussion of the new utility regulations).

Cost of Goods Sold - Cost of goods sold for the nine months ended March 31, 2023 were $2,302,380 compared to $3,033,263 for the nine months ended March 31, 2022. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 16% and 15%, respectively.

General and Administrative Expense - General and administrative expenses for the nine months ended March 31, 2023 were $2,716,428 compared to $5,114,267 for the nine months ended March 31, 2022. Such decrease was primarily due to the reduction in the expense recorded for the fair value of incentive shares of common stock earned by the Company’s executive officers under their new employment contracts, effective in March 2022.

Research and Development Expense - Research and development expenses for the nine months ended March 31, 2023 were $29,936 compared to $66,503 for the nine months ended March 31, 2022. Such fluctuation was due to a decrease in the level of the Company’s recent product development efforts.

Interest Expense - Interest expense for the nine months ended March 31, 2023 was $4,134 compared to $31,365 for the nine months ended March 31, 2022. This decrease resulted from the conversion of our 2018 and 2021 convertible notes in conjunction with the closing of our public equity offering in August 2022.

Net Loss - Net loss for the nine months ended March 31, 2023 was $2,318,927 compared to $4,677,764 for the nine months ended March 31, 2022, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

Liquidity and Capital Resources

Operating activities. Net cash used in operating activities in the nine months ended March 31, 2023 was $650,600 compared to $707,692 in the nine months ended March 31, 2022, reflecting a modest decrease in net working capital requirements in the current fiscal year period.

Financing activities. Net cash provided by financing activities in the nine months ended March 31, 2023 was $3,780,405, compared to $1,068,000 in the nine months ended March 31, 2022. As further discussed below, our net cash provided by financing activities in the nine months ended March 31, 2023 was entirely attributable to the successful completion of an underwritten public offering of our equity securities in early August 2022. Our net cash provided by financing activities in the nine months ended March 31, 2022 resulted from the issuance of our convertible notes payable to a group of accredited investors in October 2021 in the amount of $1,068,000. Such notes were ultimately converted into common stock in conjunction with the closing of our public offering in August 2022.

We completed an underwritten public offering of our equity securities in the form of Units in early August 2022. Each Unit consisted of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.00 per share. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering, including the underwriters’ exercise of the overallotment option, were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000.

In conjunction with the public offering, all holders of our 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of our 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate. As a result of the simultaneous conversion of both sets of convertible notes, the Company has fully eliminated its convertible debt.

As of March 31, 2023, we had a cash balance of $3.5 million and net working capital of approximately $6.7 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that we will have sufficient cash to operate for at least the next 12 months.

Recent Assembly Inventory Purchase

In April 2023, we closed the bulk purchase of raw materials inventory from our contract manufacturer by making a cash payment to that company in the amount of $1.3 million. This transaction was completed pursuant to an amendment of our Master Supply Agreement with our contract manufacturer. In addition to the purchase of the raw materials inventory from our contract manufacturer, this amendment provides for the eventual assumption by us of full responsibility from our contract manufacturer for the manufacturing of our proprietary Energy Storage Systems (“ESS”) units. We presently expect to assume such responsibility for the manufacturing process surrounding our ESS units from our contract manufacturer by June 1, 2023. In conjunction with assuming this responsibility, we will hire the four employees of our contract manufacturer who currently perform contract manufacturing services for us. This amended agreement has no effect on our present Sublease Agreement with our contract manufacturer, pertaining to our existing manufacturing location in Poway, CA.

Other Developments

As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. In calendar year 2022, we have experienced some negative impact of the COVID-19 pandemic on the sales of our assembled energy storage systems, primarily through a group of wholesale dealers and installers located in California. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022, for a further description of our critical accounting policies and estimates.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

As of March 31, 2023, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

Changes in internal controls over financial reporting

There was no change in our internal controls over financial reporting that occurred during the quarter ended March 31, 2023, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

ITEM 1A.

RISK FACTORS

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022 (the “Form 10-K”), under the heading “Risk Factors”, except as set forth below, which are incorporated by reference herein and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2022, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

The following are new risk factors which supplements the risk factors included in our Form 10-K:

Recent utility regulations enacted in the State of California in December 2022 have had a negative impact on the sales of our energy storage systems in that state.

On December 15, 2022, the California Public Utilities Commission (“CPUC”) unanimously passed a new statewide utility regulation known as Net Energy Metering 3.0 (“NEM 3.0”). This new regulation became effective 120 days after enactment, on April 14, 2023, and significantly alters the net billing rates for residential solar production in the State of California and ultimately impacts the monthly energy bill savings for homeowners. While this new regulation was pending, we believe that it caused a negative impact on the sales of our energy storage systems in the State of California during the recent periods ended March 31, 2023. Now that NEM 3.0 has become effective, however, we believe that it will provide an economic incentive for residential utility customers to acquire energy storage systems, such as those sold by NeoVolta, in the State of California.

An increase in mortgage interest rates may result in a decrease in demand by homeowners for our residential energy storage systems.

Sales volume in our homeowner channel is partially dependent on the construction of new homes and the sale of existing homes in our residential markets. Many customers of our installation partners rely on mortgage loans from banks and other lenders in order to finance a substantial portion of the purchase price for their home, including any related improvements. Increased mortgage interest rates may lead to lower demand for new homes and a reduced number of homes available for solar origination through our homeowner channel. Additionally, increased interest rates may result in fewer secondary home sales, a reduction in the number of customers refinancing their mortgages and uncertainty about the economy.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There have been no sales of unregistered securities during the three months ended March 31, 2023.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.

OTHER INFORMATION

None.

ITEM 6.

EXHIBITS

Exhibit No.		Exhibit Description
31.1*		Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*		Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *		Inline XBRL Instance Document
101.SCH *		Inline XBRL Taxonomy Extension Schema Document
101.CAL *		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NEOVOLTA, INC.

May 12, 2023

/s/ Brent S. Willson

Brent S. Willson

Chief Executive Officer

(Principal Executive Officer)

May 12, 2023

/s/ Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

EX-31.1 2 neovolta_ex3101.htm CERTIFICATION

Exhibit 31.1

CERTIFICATION

I, Brent S. Willson, certify that:

I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2023

/s/ Brent S. Willson

Brent S. Willson

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 neovolta_ex3102.htm CERTIFICATION

Exhibit 31.2

CERTIFICATION

I, Steve Bond, certify that:

I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2023

/s/ Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

EX-32.1 4 neovolta_ex3201.htm CERTIFICATION

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brent S. Willson, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

/s/Brent S. Willson

Brent S. Willson

Chief Executive Officer

(Principal Executive Officer)

May 12, 2023

EX-32.2 5 neovolta_ex3202.htm CERTIFICATION

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Bond, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

/s/Steve Bond

Steve Bond

Chief Financial Officer

(Principal Financial/Accounting Officer)

May 12, 2023

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg M_]C_X 02D9)1@ ! 0$ > !X #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" X 0 # 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4Z*^.OB+ M_P %$/#_ ,$?VJ-3^%_CVT73] -O;36>O0Y;RGD7)69?[N?XAT[U];Z'KFG^ M)=)M=3TJ]@U'3KI!)!=6T@>.13T((ZT 7J**^3/^"BW[47BW]E?X:^&]?\(P M6,]WJ&IFSF%\A=0GELW !ZY H ^LZ*^6_P!J;]I3Q5\&OV/]-^)NAP6,GB"X MCT]Y([E"T(\Y07P/QXKX\\$_MY?M@?$?P[!KOACX90ZWH\[,L=Y9Z9(\;D'! M .[M0!^L]%?EK_PUQ^V__P!$;D_\%$G_ ,57K'[+_P"T/^U)X\^,6E:/\2/A MJWA_PG,DAN;]M/>'80/E^8D]Z /O*BOC[]N_]O9?V3Y-&\.Z#HD?B'QEK$9F MAAG+>3!'NV@L%Y+$]%%?.=O^V%^VU?V\=U!\'',$RB2,C2)<%3R#][TH _4V MF3,T<+LB;V4$A1W]J_+C_AKC]M__ *(W)_X*)/\ XJJ+?\%-OCY\$_$FE_\ M"Y/A:NG:%>R8):UDM9F4?>,;$E20.QH ^_=!_:.T/5_%D>@7-A>:9=O,;5!@JS %)/\?I7M7P@\;6GQA^'7V>_8-?VZBWO$S\VX#AQ]>M?-8;%8 MGVU7!5Y+G6L7;=?U^O8\&CBJWMJF$JOWUK%]U_7ZE_\ X7%;?\^$WYBC_A<5 MM_SX3?F*L?\ "GM+'_+U=?F/\*/^%/Z7_P _5U^8_P *ZN7,.Z_ ZK8SR,+Q M!^T-IOAN&*6ZTJ\>*0[=T6" ?>LBV_:MT.\NH+:#1M1EGF<1QQJJDLQ.,=:S M/CQX<\.^!? \[SS3W%Y=GRK6!F'+_P![Z#K7G?P.TO3_ KH.N?%'Q-^ZT+P M_;R2Q,P^\RCYF'TZ#ZUXU3$YE]=CA836NKT3LNIY<\5C/K<<-&2N]]-D?8D$ MC20QNZ&-V4$H>JG'2I*_*:#_ (*9?M _&[7M4D^#_P *TU#0;*3;E+62ZE53 M]WS&!"AB.PJ__P - M7/P<9;:!3)(S:1+@*.2>&]*^D_V$/V$_P!K2'6=$UK14\/^,=&19;BWA),, MT9.W/M+_X*!:;\%XK72SX6N-02U:5HF\_88V8 MG=GKD>E??- !17P=^U%^T-^U'X#^,6IZ/\-OALWB#PG#'&UO?KI[S;R1\PW MCH:\3\3?MO?ME^#=!O-:UOX5)IFE6:>9<7=QI M'M/\1_"C[!H-S>1QWMT=.=!%$3\S;MW&!0!^CU1W%Q%9P/-/*D,*#+22,%51 MZDGI7._$GXAZ)\*? ^L^+/$-VMGI&EV[7$TC'D@#A5]6)X ]37R?\ /VG[+_ M (* _"/QCX>BDA\,^*[.X(^Q*S;9+8G]V_7)!&0V.A H ^S--U2SUBV%Q8W4 M-Y >!)"X=?S%6J\I_9[^$^H_"CPS<66I744LLSJ5A@)*QJHP,D]6/4D5ZM0! M^/\ ^UA$]'^.7_!4NR\#Z[)<0Z9K%E;PR2VK8D0BW=E8?B!4OE_'W_@EGXJ M++YWCOX.SS^[1*N?Q,$F/^ G%=?\2?\ E,UX2_ZY6W_I+)7Z@:QH]AX@TRYT M[4[.#4+"Y0QS6US&'CD4]05/!% 'E/[./[5?@']IWPNFJ>$M40WL:C[7I%PP M6ZMFQR&7/(_VAQ7R;_P6N_Y(3X*_[#Q_]$M63^T3_P $V?$'PS\4/\4/V;M5 MN-"UNU?[1)X>CF*AN["%CP0?^>;<=A7RI^V!^VQJ_P"T)\$M$\">//#EQH'Q M&\.ZOYMZWE>7%,@C*9*'E'R>1T]* /MO_@H#_P HV-&_ZX:/_P"@+7AG[%?_ M 4L^&?[//[/NA^"?$6FZ[TOK.U^UNVH0J MB%-P'!#'G)KTG_AEWX0_]$U\,?\ @KB_^)K?\&_!WP-\.[^:]\,>$M'T"\F3 MRY)]/LTA=U]"5'2@#\N?^"F8'_#=WPKR ?FT_@C(_P"/E:_72'_4I_NC^5?D M5_P4V=8_VZ_A8\C"-%.GDNQP /M*Y.:_72W8-;QE2&4J"&4Y!XH DK\Z/^"U MRJ?@GX))4%AK,F#CD?NZ_1>OSE_X+73Q+\%_ \32*)6UB0K&3\Q C&2!0!]1 M?LN>'[3Q7^QW\/=)OHQ):W?AZ&-P?=>#^!KQ'P3K^H?L\_&.;3]29A8^8+:Z MSP)(6/R2_AP:^@?V-_\ DUGX8?\ 8#M_Y5S_ .US\*SXF\,IXGT^#?J6EJ1. MJCF6 ]?RZUX>9X:4XQQ-+XX:_(^;SK#S=-8NA\=/7U75?UYGT#;W$=U;QS0N M)(I%#HRG(((R#1--';0R2RN(XHU+,S' R37SS^R'\6AXG\.OX5U"??J.FK MNMF8\RP'I^*_UJ7]KCXM?$GX97PSI\X34]40F9E/,4 ZGV)Z?3-=?UVG]5^ ML^7X]CH_M:A]0^O]+;>?;[SR#X@>(]0_:"^,%OIFEEFLA+]EM.X2,'YY3^OX M5Z]^UIX;L_"/[%GQ!T>QC$=M:Z$T:@=\%,_*>OTK\C/^"5Z[?VR_BL,8Q]L M&!_U\O7ZXW;+':S,S!%5&)9C@ 8ZFOR-_P""5CB3]LCXJNC!T879#*<@C[2_ M.: *_C3_ )3(:'_V&(O_ $0]?L!7Y >,E+?\%D=" &3_ &Q%_P"B'K]?Z "O M!?V[&*_LE?$K!QG3"#_WTM>]5X)^W=_R:5\2?^P8?_0EH ^??^",;'_AFC71 MG@:_-Q_VRCK[]KX!_P"",7_)M.O?]A^7_P!%1UZ#_P %'/VO(?V;/A++I.C7 M*_\ "<>(HWMK%%.6MHB,23D>P.![GVH ^2_^"BGQ^UK]J/XU:-^S[\-9&OK& MWOEAOI+*?$",=.6Y!,EO; M,OL#]I#X$Z+^T9\(];\%ZRB@741>TN=H+6UPH/ER+]#^A- M'2?"SXF:'\8/ .B^+_#MTMUI.J6ZSQL#DH2/F1O1E.01ZBNKK\@_^">?Q\UK M]D[XZ:U\ _B2[6.F75\T%L\YPEK>9^4J3_RSEXZ=R#7Z^4 ?'GBS]BWQ#X@_ M;PT3XYQ:Y91:+8K$'T]HR9FV0M&0#TZL#7V'110 5\X?M7_L,^ /VI]&EEU" MT31?%L:$6NOV<8$H/82C^-?KS[U]'T4 ?-G[3'[+^L_&O]E6Q^%>FZQ:V>I6 MRV*&^GC)C<0 G Z9Q7QSX?_ ."6OQX$Z7%INB_&2/2]/C)*6UJ\R(I/7 # M5^K-% 'Y)_%OQ5D\2 MZ);1R++IYEE82$C X8D<5]XT4 ?*W[;7[!^B_M=6^EZE%J[>&_%NE(8K;41' MYD;QD[MCJ"#UY!!R*^7;?_@F=^T/8P);V_QQD2"(;(U$\_"CI_%7ZET4 ?EQ M_P .V?VC?^BZ2?\ ?^?_ .*I^C_\$C_''CCQ/I]S\5/BQ-KFD6K@M;Q>9)*Z MYY56=L)GUQ7ZB44 9GAGPYI_A#P_IVB:5;K:Z;I\"6]O"O1448 J_<01W4$D M,R+)%(I1T89# C!!J2B@#\_OB-H>H_LU?&ZWU'3 18&4W=EDD+)$3\\)/U_I M3? >DZG^TS\<)[[45/V'S!=7F.5AA4_)$/KT_&OJS]I+X2CXL?#NYM[6(-K= MCFXL&[EQU3Z-47[,_P )/^%4_#RWCO(0FNZABXOF[JQ'"?11Q7SO]GOV_L_^ M7=^;_@?UT/S7^PJW]I?5M?JU^?ROMR_UT/5[6VBL[>*W@18H8E"(BC 50, " ML[Q9X7T[QMX9U/0-7MQ=:9J-N]M<0G^)&&#^-:U%?1'Z5L?ESJ7_ 20\>^! M?$=_-\+_ (M3:+H]TY*P2>9'*JYX5RC8B@#\M+G_ ()F_M"ZA;R6MU\<9)+:92DBF>?!4]1]ZOJC]B?]A?1/V0]- MU6[.JMXB\5ZLJI=ZDT?EHL8.0B*22!DDDDY-?4=% 'YP_M+_ /!-3X@?%[]H MC6?B5X9\;V7A][F1)+4[7$T)"XR&4]?\:Y;_ (=L_M&_]%TD_P"_\_\ \57Z MCT4 ?ENW_!-?]HTJ1_PO20_]MY__ (JOL+5OV>?$^O?L=S?"?4O$27_B:?2A M8RZQ<997DR"6.>3TKZ&HH ^:?V#_ -E_6_V4?A/JGA;6M5M=7NKK4GO4EM4* MJJE%7:<^Z_K7A/BK_@G'XT^-_P"T_%\2?BGXML-3\/I=B4:-:QL"MO&F3WYK]#** (K6UAL;6&VMXEAMX46..-!A44# '8 "I:** /BK]NS_@GN M/VHO$&B>+?"VJVWAOQ99@0W5S*AVW,8Y1B5YWJ0,'TKZ5^!'A_QEX3^%^BZ+ MX\U.UUKQ%81?9Y=0M00MPB\(Q!_BQC/TKT"B@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH %HH __]D! end EX-101.SCH 7 neov-20230331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Equity (Details - Warrant activity) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 neov-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 neov-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 neov-20230331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants, each warrant exercisable for one share of common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Dealer [Member] Two Dealers [Member] Thrid Dealer [Member] Accounts Receivable [Member] Three Dealers [Member] Antidilutive Securities [Axis] Warrants [Member] Warrants Underwriters [Member] Restricted Stock [Member] Long-Term Debt, Type [Axis] Convertible Debt [Member] Sale of Stock [Axis] IPO [Member] Securities Financing Transaction [Axis] Public Offering [Member] Warrant [Member] Convertible Debt 1 [Member] Counterparty Name [Axis] Three Independent Directors [Member] Transaction Type [Axis] Amortized Value of RSUs Granted [Member] Amortized Value Of New Compensation Plan [Member] Amortized Value Of Shares Granted To Various Advisors [Member] Fair Value Of Incentive Shares [Member] Various Grantees [Member] Executive Officers [Member] Fair Value Of Bonus Shares Earned [Member] Amortized Value Of Shares Granted To Attorney [Member] Amortized Value Of Shares To New Independent Director [Member] Fair Value Of Incentive Shares Wholesale Dealer [Member] Plan Name [Axis] 2019 Stock Option Plan [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Two Executives [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventory Prepaid insurance and other current assets Total current assets Total assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued interest payable Other accrued liabilities Convertible notes payable Total current liabilities Convertible notes payable Total liabilities Commitments and contingencies (Note 4) Stockholders' equity: Common stock, $0.001 par value, 100,000,000 shares authorized, 33,155,127 and 21,977,251 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues from contracts with customers Cost of goods sold Gross profit Operating expenses: General and administrative Research and development Total operating expenses Loss from operations Other income (expense): Interest expense Total other income (expense) Net loss Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic Earnings Per Share, Diluted Beginning balance, value Beginning balance, shares Issuance of common stock in underwritten public offering Issuance of common stock in underwritten public offering, shares Issuance of common stock for conversion of debt and accrued interest Issuance of common stock for conversion of debt and accrued interest, shares Stock compensation expense Stock compensation expense, shares Adjustment for change in accounting principle Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operations: Stock compensation expense Bad debt expense Changes in current assets and liabilities Accounts receivable Inventory Prepaid insurance and other current assets Accounts payable Accrued expenses Net cash flows used in operating activities Cash flows from financing activities: Underwritten public offering of common stock Proceeds from convertible notes payable Net cash flows provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosures of cash flow information Cash paid for interest Cash paid for income taxes Supplemental non-cash financing activities Conversion of convertible debt and accrued interest into common stock Adjustment of debt discount related to adoption of new accounting principle Organization, Consolidation and Presentation of Financial Statements [Abstract] Business and Summary of Significant Accounting Policies EX-101.PRE 11 neov-20230331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	9 Months Ended
Cover - shares	Mar. 31, 2023	May 12, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--06-30
Entity File Number	001-41447
Entity Registrant Name	NeoVolta, Inc.
Entity Central Index Key	0001748137
Entity Tax Identification Number	82-5299263
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	13651 Danielson Street
Entity Address, Address Line Two	Suite A
Entity Address, City or Town	Poway
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92064
City Area Code	(800)
Local Phone Number	364-5464
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		33,155,127
Common Stock, par value $0.001 per share
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	NEOV
Security Exchange Name	NASDAQ
Warrants, each warrant exercisable for one share of common stock
Title of 12(b) Security	Warrants, each warrant exercisable for one share of common stock
Trading Symbol	NEOVW
Security Exchange Name	NASDAQ

XML 13 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Current assets:
Cash and cash equivalents	$ 3,460,190	$ 330,385
Accounts receivable, net	1,737,651	1,317,738
Inventory	1,362,289	2,238,208
Prepaid insurance and other current assets	205,710	239,001
Total current assets	6,765,840	4,125,332
Total assets	6,765,840	4,125,332
Current liabilities:
Accounts payable	0	205,600
Accrued interest payable	0	53,436
Other accrued liabilities	87,651	127,356
Convertible notes payable	0	1,068,000
Total current liabilities	87,651	1,454,392
Convertible notes payable	0	53,716
Total liabilities	87,651	1,508,108
Commitments and contingencies (Note 4)
Stockholders' equity:
Common stock, $0.001 par value, 100,000,000 shares authorized, 33,155,127 and 21,977,251 shares issued and outstanding	33,155	21,978
Additional paid-in capital	24,763,356	18,394,641
Accumulated deficit	(18,118,322)	(15,799,395)
Total stockholders' equity	6,678,189	2,617,224
Total liabilities and stockholders' equity	$ 6,765,840	$ 4,125,332

XML 14 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2023	Jun. 30, 2022
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	33,155,127	21,977,251
Common Stock, Shares, Outstanding	33,155,127	21,977,251

XML 15 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations (Unaudited) - USD ($)	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues from contracts with customers	$ 629,010	$ 932,903	$ 2,733,951	$ 3,567,634
Cost of goods sold	537,261	810,563	2,302,380	3,033,263
Gross profit	91,749	122,340	431,571	534,371
Operating expenses:
General and administrative	723,271	620,214	2,716,428	5,114,267
Research and development	1,290	0	29,936	66,503
Total operating expenses	724,561	620,214	2,746,364	5,180,770
Loss from operations	(632,812)	(497,874)	(2,314,793)	(4,646,399)
Other income (expense):
Interest expense	0	(21,829)	(4,134)	(31,365)
Total other income (expense)	0	(21,829)	(4,134)	(31,365)
Net loss	$ (632,812)	$ (519,703)	$ (2,318,927)	$ (4,677,764)

XML 16 R5.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Weighted Average Number of Shares Outstanding, Basic	33,151,685	20,287,634	31,650,491	20,082,627
Weighted Average Number of Shares Outstanding, Diluted	33,151,685	20,287,634	31,650,491	20,082,627
Earnings Per Share, Basic	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.23)
Earnings Per Share, Diluted	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.23)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

+ Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2021	$ 19,641	$ 13,169,363	$ (10,040,370)	$ 3,148,634
Beginning balance, shares at Jun. 30, 2021	19,640,888
Issuance of common stock for conversion of debt and accrued interest	$ 204	1,079		1,283
Issuance of common stock for conversion of debt and accrued interest, shares	203,630
Stock compensation expense	$ 154	130,469		130,623
Adjustment for change in accounting principle		(87,116)	45,809	(41,307)
Net loss			(128,207)	(128,207)
Ending balance, value at Sep. 30, 2021	$ 19,999	13,213,795	(10,122,768)	3,111,026
Ending balance, shares at Sep. 30, 2021	19,998,683
Beginning balance, value at Jun. 30, 2021	$ 19,641	13,169,363	(10,040,370)	3,148,634
Beginning balance, shares at Jun. 30, 2021	19,640,888
Net loss				(4,677,764)
Ending balance, value at Mar. 31, 2022	$ 21,978	17,448,202	(14,672,325)	2,797,855
Ending balance, shares at Mar. 31, 2022	21,977,251
Beginning balance, value at Sep. 30, 2021	$ 19,999	13,213,795	(10,122,768)	3,111,026
Beginning balance, shares at Sep. 30, 2021	19,998,683
Stock compensation expense		3,870,935		3,870,935
Net loss			(4,029,854)	(4,029,854)
Ending balance, value at Dec. 31, 2021	$ 19,999	17,084,730	(14,152,622)	2,952,107
Ending balance, shares at Dec. 31, 2021	19,998,683
Issuance of common stock for conversion of debt and accrued interest	$ 895	4,744		5,639
Issuance of common stock for conversion of debt and accrued interest, shares	895,000
Stock compensation expense	$ 1,084	358,728		359,812
Stock compensation expense, shares	1,083,568
Net loss			(519,703)	(519,703)
Ending balance, value at Mar. 31, 2022	$ 21,978	17,448,202	(14,672,325)	2,797,855
Ending balance, shares at Mar. 31, 2022	21,977,251
Beginning balance, value at Jun. 30, 2022	$ 21,978	18,394,641	(15,799,395)	2,617,224
Beginning balance, shares at Jun. 30, 2022	21,977,251
Issuance of common stock in underwritten public offering	$ 1,121	3,779,284		3,780,405
Issuance of common stock in underwritten public offering, shares	1,121,250
Issuance of common stock for conversion of debt and accrued interest	$ 9,672	1,169,614		1,179,286
Issuance of common stock for conversion of debt and accrued interest, shares	9,671,867
Stock compensation expense		591,816		591,816
Stock compensation expense, shares	154,165
Net loss			(698,586)	(698,586)
Ending balance, value at Sep. 30, 2022	$ 32,771	23,935,355	(16,497,981)	7,470,145
Ending balance, shares at Sep. 30, 2022	32,770,368
Beginning balance, value at Jun. 30, 2022	$ 21,978	18,394,641	(15,799,395)	2,617,224
Beginning balance, shares at Jun. 30, 2022	21,977,251
Net loss				(2,318,927)
Ending balance, value at Mar. 31, 2023	$ 33,155	24,763,356	(18,118,322)	6,678,189
Ending balance, shares at Mar. 31, 2023	33,155,127
Beginning balance, value at Sep. 30, 2022	$ 32,771	23,935,355	(16,497,981)	7,470,145
Beginning balance, shares at Sep. 30, 2022	32,770,368
Stock compensation expense	$ 75	719,220		719,295
Stock compensation expense, shares	75,000
Net loss			(987,529)	(987,529)
Ending balance, value at Dec. 31, 2022	$ 32,846	24,654,575	(17,485,510)	7,201,911
Ending balance, shares at Dec. 31, 2022	32,845,368
Stock compensation expense	$ 309	108,781		109,090
Stock compensation expense, shares	309,759
Net loss			(632,812)	(632,812)
Ending balance, value at Mar. 31, 2023	$ 33,155	$ 24,763,356	$ (18,118,322)	$ 6,678,189
Ending balance, shares at Mar. 31, 2023	33,155,127

XML 18 R7.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (2,318,927)	$ (4,677,764)
Adjustments to reconcile net loss to net cash used in operations:
Stock compensation expense	1,420,201	4,361,370
Bad debt expense	380,000	0
Changes in current assets and liabilities
Accounts receivable	(799,913)	(232,921)
Inventory	875,919	(15,481)
Prepaid insurance and other current assets	33,291	(119,086)
Accounts payable	(205,600)	(49,343)
Accrued expenses	(35,571)	25,533
Net cash flows used in operating activities	(650,600)	(707,692)
Cash flows from financing activities:
Underwritten public offering of common stock	3,780,405	0
Proceeds from convertible notes payable	0	1,068,000
Net cash flows provided by financing activities	3,780,405	1,068,000
Net increase in cash and cash equivalents	3,129,805	360,308
Cash and cash equivalents at beginning of period	330,385	425,681
Cash and cash equivalents at end of period	3,460,190	785,989
Supplemental disclosures of cash flow information
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Supplemental non-cash financing activities
Conversion of convertible debt and accrued interest into common stock	1,179,286	6,922
Adjustment of debt discount related to adoption of new accounting principle	$ 0	$ 87,116

XML 19 R8.htm IDEA: XBRL DOCUMENT

Business and Summary of Significant Accounting Policies

9 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business and Summary of Significant Accounting Policies

(1) Business and Summary of Significant Accounting Policies

Schedule of inventory
	March 31,		June 30,
	2023		2022

Raw materials	$	1,299,494	$	1,844,049
Work in process		62,795		22,768
Finished goods		–		371,391

Total	$	1,362,289	$	2,238,208

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

Research and Development Costs – Research and development costs are expensed as incurred.

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

At March 31, 2023 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Notes Payable

9 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Notes Payable

(2) Notes Payable

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

XML 21 R10.htm IDEA: XBRL DOCUMENT

Equity

9 Months Ended

Mar. 31, 2023

Equity [Abstract]

Equity

(3) Equity

The following table presents activity with respect to the Company’s warrants for the nine months ended March 31, 2023:

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at July 1, 2022

–

Warrants issued to Public Investors

1,121,250

4.00

–

Warrants issued to Underwriters

58,500

4.40

–

Outstanding at March 31, 2023

1,179,750

4.02

4.3

–

Exercisable at March 31, 2023

1,179,750

4.02

4.3

–

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

+ Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

9 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

(4) Commitments and Contingencies

XML 23 R12.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Mar. 31, 2023

Subsequent Events [Abstract]

Subsequent Events

(5) Subsequent Events

XML 24 R13.htm IDEA: XBRL DOCUMENT

Business and Summary of Significant Accounting Policies (Policies)

9 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Interim Financial Information

Cash and Cash Equivalents

Inventory

Schedule of inventory
	March 31,		June 30,
	2023		2022

Raw materials	$	1,299,494	$	1,844,049
Work in process		62,795		22,768
Finished goods		–		371,391

Total	$	1,362,289	$	2,238,208

Revenue Recognition

	·	Identification of the contract with a customer
	·	Identification of the performance obligations in the contract
	·	Determination of the transaction price
	·	Allocation of the transaction price to the performance obligations in the contract
	·	Recognition of revenue when, or as, the Company satisfies a performance obligation

Allowance for Doubtful Accounts

Income Taxes

Stock Compensation Expense

Loss Per Common Share

Research and Development Costs

Research and Development Costs – Research and development costs are expensed as incurred.

Use of Estimates

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

At March 31, 2023 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

Recent Accounting Pronouncements

Liquidity

XML 25 R14.htm IDEA: XBRL DOCUMENT

Business and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of inventory

Schedule of inventory
	March 31,		June 30,
	2023		2022

Raw materials	$	1,299,494	$	1,844,049
Work in process		62,795		22,768
Finished goods		–		371,391

Total	$	1,362,289	$	2,238,208

XML 26 R15.htm IDEA: XBRL DOCUMENT

Equity (Tables)

9 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of warrants activity

Number

Wtd. Avg.

Aggregate

Exercise

Remaining

Intrinsic

Price

Term (Yrs.)

Value

Outstanding at July 1, 2022

–

Warrants issued to Public Investors

1,121,250

4.00

–

Warrants issued to Underwriters

58,500

4.40

–

Outstanding at March 31, 2023

1,179,750

4.02

4.3

–

Exercisable at March 31, 2023

1,179,750

4.02

4.3

–

XML 27 R16.htm IDEA: XBRL DOCUMENT

Business and Summary of Significant Accounting Policies (Details Inventory) - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 1,299,494	$ 1,844,049
Work in process	62,795	22,768
Finished goods	0	371,391
Total	$ 1,362,289	$ 2,238,208

XML 28 R17.htm IDEA: XBRL DOCUMENT

Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Product Information [Line Items]
FDIC uninsured amount	$ 3,028,474
Inventory Valuation Reserves	0		$ 0
Allowance for doubtful accounts	380,000
Liabilities, Fair Value Disclosure	0
Assets, Fair Value Disclosure	$ 0
Common Stock [Member]
Product Information [Line Items]
Antidilutive shares	1,229,750
Warrants [Member]
Product Information [Line Items]
Antidilutive shares	1,121,250
Warrants Underwriters [Member]
Product Information [Line Items]
Antidilutive shares	58,500
Restricted Stock [Member]
Product Information [Line Items]
Antidilutive shares	50,000
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Dealer [Member]
Product Information [Line Items]
Concentration Risk, Percentage	21.00%	22.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Two Dealers [Member]
Product Information [Line Items]
Concentration Risk, Percentage	18.00%	16.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Thrid Dealer [Member]
Product Information [Line Items]
Concentration Risk, Percentage	16.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Three Dealers [Member]
Product Information [Line Items]
Concentration Risk, Percentage	83.00%

XML 29 R18.htm IDEA: XBRL DOCUMENT

Notes Payable (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended
Notes Payable (Details Narrative) - USD ($)	Aug. 31, 2022	Oct. 31, 2021	Mar. 31, 2023	Mar. 31, 2022
Debt Instrument [Line Items]
Conversion of Stock, Amount Converted	$ 59,251
Shares converted	9,404,867			1,098,630
Conversion price	$ 0.0063
Proceeds from Convertible Debt			$ 0	$ 1,068,000
Convertible Debt [Member]
Debt Instrument [Line Items]
Conversion of Stock, Amount Converted			$ 59,251
Shares converted		267,000	9,404,867
Conversion price		$ 4.00
Proceeds from Convertible Debt		$ 1,068,000
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Common Stock [Member]
Debt Instrument [Line Items]
Number of shares converted	9,671,867

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482900/835-30-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

+ Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Equity (Details - Warrant activity)	9 Months Ended
Equity (Details - Warrant activity)	Mar. 31, 2023 USD ($) $ / shares shares
Equity [Abstract]
Class of Warrant or Right, Outstanding \| shares	0
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 0
Warrants issued to public investors \| shares	1,121,250
Warrant issued to public investors, weighted average excercise price \| $ / shares	$ 4.00
Warrants issued to underwriters \| shares	58,500
Warrant issued to underwriters, weighted average excercise price \| $ / shares	$ 4.40
Class of Warrant or Right, Outstanding \| shares	1,179,750
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 4.02
Warrants and Rights Outstanding, Term	4 years 3 months 18 days
Aggregate intrinsic value, outstanding \| $	$ 0
Warrant exercisable, shares \| shares	1,179,750
Warrants exercisable, weighted average exercise price \| $ / shares	$ 4.02
Warrants term, exercisable	4 years 3 months 18 days
Warrant exercisable, aggregate intrinsic value \| $	$ 0

XML 31 R20.htm IDEA: XBRL DOCUMENT

Equity (Details Narrative) - USD ($)	1 Months Ended		5 Months Ended	6 Months Ended	9 Months Ended
Equity (Details Narrative) - USD ($)	Aug. 31, 2022	Oct. 31, 2021	Mar. 31, 2023	Dec. 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022	Feb. 28, 2019
Subsidiary, Sale of Stock [Line Items]
Exercise price	$ 4.00		$ 4.02		$ 4.02		$ 0
Proceeds from Issuance Initial Public Offering					$ 3,780,405	$ 0
Amounts converted	$ 59,251
Shares converted	9,404,867					1,098,630
Proceeds from Convertible Debt					0	$ 1,068,000
Debt Conversion, Converted Instrument, Amount						6,922
Share-Based Payment Arrangement, Noncash Expense					1,420,201	4,361,370
2019 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized								2,500,000
Amortized Value of RSUs Granted [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense					1,200,723	193,314
Amortized Value Of New Compensation Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense					131,625
Amortized Value Of Shares Granted To Various Advisors [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense					60,625
Fair Value Of Incentive Shares [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense					27,228	3,505,000
Fair Value Of Bonus Shares Earned [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense						175,250
Amortized Value Of Shares Granted To Attorney [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense						236,619
Amortized Value Of Shares To New Independent Director [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense						$ 191,125
Fair Value Of Incentive Shares Wholesale Dealer [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Payment Arrangement, Noncash Expense				$ 60,062
Three Independent Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Accrued compensation expenses			$ 146,250		$ 146,250
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period			26,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture			$ 97,500
Various Grantees [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period					384,759
Executive Officers [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period					75,000
Two Executives [Member] \| Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period					450,000
Convertible Debt [Member]
Subsidiary, Sale of Stock [Line Items]
Amounts converted					$ 59,251
Shares converted		267,000			9,404,867
Proceeds from Convertible Debt		$ 1,068,000
Convertible Debt 1 [Member]
Subsidiary, Sale of Stock [Line Items]
Shares converted					267,000
Proceeds from Convertible Debt					$ 1,068,000
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price			$ 4.40		$ 4.40
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant			58,500		58,500
Number of shares exercisable			1,179,750		1,179,750
Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from Issuance or Sale of Equity					$ 3,780,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction					1,121,250
Sale of Stock, Price Per Share			$ 4.00		$ 4.00
Proceeds from Issuance Initial Public Offering					$ 4,485,000

XML 32 neovolta_i10q-033123_htm.xml IDEA: XBRL DOCUMENT 0001748137 2022-07-01 2023-03-31 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2022-07-01 2023-03-31 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2022-07-01 2023-03-31 0001748137 2023-05-12 0001748137 2023-03-31 0001748137 2022-06-30 0001748137 2023-01-01 2023-03-31 0001748137 2022-01-01 2022-03-31 0001748137 2021-07-01 2022-03-31 0001748137 us-gaap:CommonStockMember 2022-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001748137 us-gaap:RetainedEarningsMember 2022-06-30 0001748137 us-gaap:CommonStockMember 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-09-30 0001748137 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-12-31 0001748137 2022-12-31 0001748137 us-gaap:CommonStockMember 2021-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001748137 us-gaap:RetainedEarningsMember 2021-06-30 0001748137 2021-06-30 0001748137 us-gaap:CommonStockMember 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-09-30 0001748137 2021-09-30 0001748137 us-gaap:CommonStockMember 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-12-31 0001748137 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001748137 2022-07-01 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001748137 2022-10-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001748137 2021-07-01 2021-09-30 0001748137 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001748137 2021-10-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001748137 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001748137 us-gaap:CommonStockMember 2023-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001748137 us-gaap:RetainedEarningsMember 2023-03-31 0001748137 us-gaap:CommonStockMember 2022-03-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001748137 us-gaap:RetainedEarningsMember 2022-03-31 0001748137 2022-03-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:TwoDealersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:ThridDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:ThreeDealersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2023-03-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001748137 NEOV:TwoDealersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2022-03-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2023-03-31 0001748137 NEOV:WarrantsMember 2022-07-01 2023-03-31 0001748137 NEOV:WarrantsUnderwritersMember 2022-07-01 2023-03-31 0001748137 us-gaap:RestrictedStockMember 2022-07-01 2023-03-31 0001748137 us-gaap:CommonStockMember 2022-08-01 2022-08-31 0001748137 2022-08-01 2022-08-31 0001748137 2022-08-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-01 2021-10-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-31 0001748137 us-gaap:IPOMember 2022-07-01 2023-03-31 0001748137 us-gaap:IPOMember 2023-03-31 0001748137 NEOV:PublicOfferingMember 2022-07-01 2023-03-31 0001748137 us-gaap:WarrantMember 2023-03-31 0001748137 us-gaap:ConvertibleDebtMember 2022-07-01 2023-03-31 0001748137 NEOV:ConvertibleDebt1Member 2022-07-01 2023-03-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2023-03-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2022-11-01 2023-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2022-07-01 2023-03-31 0001748137 NEOV:AmortizedValueOfNewCompensationPlanMember 2022-07-01 2023-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2022-07-01 2023-03-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2022-07-01 2023-03-31 0001748137 NEOV:VariousGranteesMember 2022-07-01 2023-03-31 0001748137 NEOV:ExecutiveOfficersMember 2022-07-01 2023-03-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2021-07-01 2022-03-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2021-07-01 2022-03-31 0001748137 NEOV:FairValueOfBonusSharesEarnedMember 2021-07-01 2022-03-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToAttorneyMember 2021-07-01 2022-03-31 0001748137 NEOV:AmortizedValueOfSharesToNewIndependentDirectorMember 2021-07-01 2022-03-31 0001748137 NEOV:FairValueOfIncentiveSharesWholesaleDealerMember 2021-07-01 2021-12-31 0001748137 NEOV:StockOptionPlan2019Member 2019-02-28 0001748137 NEOV:TwoExecutivesMember us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2023-03-31 iso4217:USD shares iso4217:USD shares pure 0001748137 false --06-30 2023 Q3

10-Q true 2023-03-31 false 001-41447 NeoVolta, Inc. NV 82-5299263 13651 Danielson Street Suite A Poway CA 92064 (800) 364-5464 Common Stock, par value $0.001 per share NEOV NASDAQ Warrants, each warrant exercisable for one share of common stock NEOVW NASDAQ Yes Yes Non-accelerated Filer true true false false 33155127

3460190

330385

1737651

1317738

1362289

2238208

205710

239001

6765840

4125332

6765840

4125332

205600

53436

87651

127356

1068000

87651

1454392

53716

87651

1508108

0.001

100000000

33155127

21977251

33155

21978

24763356

18394641

-18118322

-15799395

6678189

2617224

6765840

4125332

629010

932903

537261

810563

91749

122340

723271

620214

1290

724561

620214

-632812

-497874

-0

21829

-21829

-632812

-519703

33151685

20287634

-0.02

-0.03

2733951

3567634

2302380

3033263

431571

534371

2716428

5114267

29936

66503

2746364

5180770

-2314793

-4646399

4134

31365

-4134

-31365

-2318927

-4677764

31650491

20082627

-0.07

-0.23

21977251

21978

18394641

-15799395

2617224

1121250

1121

3779284

3780405

9671867

9672

1169614

1179286

591816

-698586

32770368

32771

23935355

-16497981

7470145

75000

719220

719295

-987529

32845368

32846

24654575

-17485510

7201911

309759

309

108781

109090

-632812

33155127

33155

24763356

-18118322

6678189

19640888

19641

13169363

-10040370

3148634

203630

204

1079

1283

154165

154

130469

130623

-87116 45809 -41307

-128207

19998683

19999

13213795

-10122768

3111026

3870935

-4029854

19998683

19999

17084730

-14152622

2952107

895000

895

4744

5639

1083568

1084

358728

359812

-519703

21977251

21978

17448202

-14672325

2797855

-2318927

-4677764

1420201

4361370

380000

799913

232921

-875919

15481

-33291

119086

-205600

-49343

-35571

25533

-650600

-707692

3780405

1068000

3780405

1068000

3129805

360308

330385

425681

3460190

785989

1179286 6922 0 87116

<p id="xdx_808_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zd99JljxVVoa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Business and Summary of Significant Accounting Policies Description of Business – NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3). Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2023, the results of its operations for the three and nine month periods ended March 31, 2023 and 2022, the changes in its stockholders’ equity for the nine month periods ended March 31, 2023 and 2022, and cash flows for the nine month periods ended March 31, 2023 and 2022. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022. Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2023, the Company maintained accounts at two different banks, of which the balance at the first bank was within the FDIC insurance limit while the balance at the second bank was in excess of the FDIC insurance limit by $3,028,474. Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of March 31, 2023 and June 30, 2022: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zam4lHlbmpwg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> Schedule of inventory</td><td> </td> <td colspan="2" id="xdx_497_20230331" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_490_20220630" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINznZ7_zPAgsL7Jqgw9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,299,494</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINznZ7_zNtBY6c01WEd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINznZ7_zZVGwvEwZ0di" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_mtINznZ7_z4NXxIpDKkA6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,362,289</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2023 and June 30, 2022. Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zs3TR1wkhbF5" title="Concentration Risk, Percentage">21%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_zKCtvu0uyRN5" title="Concentration Risk, Percentage">18% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThridDealerMember_zzHlYSSBYrwc" title="Concentration Risk, Percentage">16% of the Company’s revenues in the nine months ended March 31, 2023, however, no other dealers accounted for more than 10% of the revenues in such period. Those same three dealers represented an aggregate of approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeDealersMember_zobANdIbTbof" title="Concentration Risk, Percentage">83% of the Company’s accounts receivable as of March 31, 2023 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of March 31, 2023. Two dealers represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zwPipTKl6FFj" title="Concentration Risk, Percentage">22%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_za0RduG9sEq2" title="Concentration Risk, Percentage">16% of the Company’s revenues in the nine months ended March 31, 2022. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2023 and 2022 is provided. Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2023 and June 30, 2022, our allowance for doubtful accounts was $380,000 and zero, respectively. Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates. Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period. Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2023, the Company had total outstanding common stock equivalents of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_pdd" title="Antidilutive shares">1,229,750 shares as follows: (i) <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_pdd" title="Antidilutive shares">1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsUnderwritersMember_pdd" title="Antidilutive shares">58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_pdd" title="Antidilutive shares">50,000 shares related to restricted stock units granted to an officer in March 2022 (see Note 3). Research and Development Costs – Research and development costs are expensed as incurred. Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time. Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party. <p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zipVdePhPDLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 - Inputs that are both significant to the fair value measurement and unobservable. The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates. At March 31, 2023 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis. Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements. Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

Description of Business – NeoVolta Inc. (“we”, “our” or the "Company") is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3). Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of March 31, 2023, the results of its operations for the three and nine month periods ended March 31, 2023 and 2022, the changes in its stockholders’ equity for the nine month periods ended March 31, 2023 and 2022, and cash flows for the nine month periods ended March 31, 2023 and 2022. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000, per bank. At March 31, 2023, the Company maintained accounts at two different banks, of which the balance at the first bank was within the FDIC insurance limit while the balance at the second bank was in excess of the FDIC insurance limit by $3,028,474.

3028474

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of March 31, 2023 and June 30, 2022: <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zam4lHlbmpwg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> Schedule of inventory</td><td> </td> <td colspan="2" id="xdx_497_20230331" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_490_20220630" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINznZ7_zPAgsL7Jqgw9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,299,494</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINznZ7_zNtBY6c01WEd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINznZ7_zZVGwvEwZ0di" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_mtINznZ7_z4NXxIpDKkA6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,362,289</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of March 31, 2023 and June 30, 2022.

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zam4lHlbmpwg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="text-align: left"> Schedule of inventory</td><td> </td> <td colspan="2" id="xdx_497_20230331" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_490_20220630" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINznZ7_zPAgsL7Jqgw9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,299,494</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINznZ7_zNtBY6c01WEd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINznZ7_zZVGwvEwZ0di" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_mtINznZ7_z4NXxIpDKkA6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,362,289</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1299494

1844049

62795

22768

371391

1362289

2238208

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update ("ASU") 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in">·</td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zs3TR1wkhbF5" title="Concentration Risk, Percentage">21%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_zKCtvu0uyRN5" title="Concentration Risk, Percentage">18% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThridDealerMember_zzHlYSSBYrwc" title="Concentration Risk, Percentage">16% of the Company’s revenues in the nine months ended March 31, 2023, however, no other dealers accounted for more than 10% of the revenues in such period. Those same three dealers represented an aggregate of approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeDealersMember_zobANdIbTbof" title="Concentration Risk, Percentage">83% of the Company’s accounts receivable as of March 31, 2023 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of March 31, 2023. Two dealers represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zwPipTKl6FFj" title="Concentration Risk, Percentage">22%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_za0RduG9sEq2" title="Concentration Risk, Percentage">16% of the Company’s revenues in the nine months ended March 31, 2022. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the nine months ended March 31, 2023 and 2022 is provided.

0.21

0.18

0.16

0.83

0.22

0.16

Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of March 31, 2023 and June 30, 2022, our allowance for doubtful accounts was $380,000 and zero, respectively.

380000

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2023, the Company had total outstanding common stock equivalents of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_pdd" title="Antidilutive shares">1,229,750 shares as follows: (i) <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_pdd" title="Antidilutive shares">1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsUnderwritersMember_pdd" title="Antidilutive shares">58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_pdd" title="Antidilutive shares">50,000 shares related to restricted stock units granted to an officer in March 2022 (see Note 3).

1229750

1121250

58500

50000

Research and Development Costs – Research and development costs are expensed as incurred.

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

<p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zipVdePhPDLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 - Inputs that are both significant to the fair value measurement and unobservable. The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates. At March 31, 2023 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. We anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

(2) Notes Payable In conjunction with the closing of our underwritten public offering in August 2022 (see Note 3), all holders of the Company’s two outstanding series of convertible notes payable, which were originally issued to various accredited investors in May 2018 and October 2021, agreed to convert their debt into a total of 9,671,867 shares of our common stock at the respective conversion rates. Each of these two series of our converted notes payable is further described below. In May 2018, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $104,688. Each unsecured note originally bore interest at a rate of 12% per annum, which was later reduced by mutual agreement to 3.99% per annum in May 2019. Subsequently, the holders of certain of these notes elected to convert or exchange certain portions of their convertible notes payable into shares of our common stock, based upon the stated conversion rate of $0.0063 per share. As of the closing of our underwritten public offering in August 2022, the holders of the remaining balance of such unconverted notes in the total amount of $59,251, including accrued interest, agreed to convert their debt into a total of 9,404,867 shares of our common stock at the stated conversion rate of $0.0063 per share. In October 2021, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $1,068,000. Each unsecured note bore interest at a rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20211031__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zJ4yGf6uDwuh" title="Debt Instrument, Interest Rate, Stated Percentage">6% per annum. As of the closing of our underwritten public offering in August 2022, pursuant to the terms of such convertible notes, the notes were automatically converted into a total of 267,000 shares of our common stock at the stated conversion rate of $4.00 of principal per share.

9671867

59251

9404867

0.0063

1068000

0.06

267000

4.00

(3) Equity Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance. In the underwritten public offering, a total of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220701__20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Sale of Stock, Number of Shares Issued in Transaction">1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220701__20230331__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from Issuance Initial Public Offering">4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220701__20230331__us-gaap--SecuritiesFinancingTransactionAxis__custom--PublicOfferingMember_pp0p0" title="Proceeds from Issuance or Sale of Equity">3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant">58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years. In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate (see Note 2). In the nine months ended March 31, 2022, the holders of the 2018 convertible notes payable having total principal and accrued interest balances in the aggregate amount of $6,922 elected to convert their notes. Based upon the stated conversion price of $0.0063 per share, these holders converted their notes payable into a total of 1,098,630 shares of common stock (see Note 2). Warrants – The Warrants for a total of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Number of shares exercisable">1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus. The following table presents activity with respect to the Company’s warrants for the nine months ended March 31, 2023: <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zWb0QV7nNGs2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of warrants activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at July 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20220701__20230331_zVXNft8hhKJg" style="text-align: right" title="Class of Warrant or Right, Outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20220701__20230331_zvcDlSOIf07k" style="text-align: right" title="Class of Warrant or Right, Exercise Price of Warrants or Rights">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 32%; text-align: left">Warrants issued to Public Investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--WarrantsIssuedToPublicInvestors_c20220701__20230331_zKHxhnR2yK01" style="width: 13%; text-align: right" title="Warrants issued to public investors">1,121,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--WarrantIssuedToPublicInvestorsWeightedAverageExcercisePrice_c20220701__20230331_zdyV4W0ij3Mi" style="width: 13%; text-align: right" title="Warrant issued to public investors, weighted average excercise price">4.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants issued to Underwriters</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--WarrantsIssuedToUnderwriters_c20220701__20230331_zXykRyhw35uc" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants issued to underwriters">58,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--WarrantIssuedToUnderwritersWeightedAverageExcercisePrice_c20220701__20230331_zXLAjRGMtJkk" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant issued to underwriters, weighted average excercise price">4.40</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220701__20230331_z301vhi9Jt85" style="border-bottom: Black 2.5pt double; text-align: right" title="Class of Warrant or Right, Outstanding">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220701__20230331_zRFCPXZmA0Qi" style="border-bottom: Black 2.5pt double; text-align: right" title="Class of Warrant or Right, Exercise Price of Warrants or Rights">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_d0_c20230331_zt2PETFiHOKg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value, outstanding">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_982_ecustom--WarrantsExercisableShares_c20230331_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable, shares">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--WarrantsExercisableWeightedAverageExercisePrice_c20230331_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_d0_c20230331_z6eQUNaa9mki" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized. Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement was one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of January 1, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to the CEO as of that date. In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to the CFO as of that date. Based upon the Company’s assessment of the probability of the CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, the Company has calculated the grant date value of such awards and is amortizing it as stock compensation expense over the underlying performance periods. The Company has recognized stock compensation expense applicable to such RSU awards in the nine months ended March 31, 2023 in the amount of $1,200,723. In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of March 31, 2023, we booked an initial accrual of $146,250 of compensation expense (of which $131,625 will be settled through the issuance of shares) for our three independent directors under this plan. At the same time, we also granted <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20221101__20230331__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period">26,000 shares, with a grant date value of $<span id="xdx_90C_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_c20221101__20230331__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_pp0p0" title="Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture">97,500, to various advisors pursuant to annual contracts for their services. In the nine months ended March 31, 2023, we recognized total non-cash stock compensation expense of $1,420,201 as follows: (i) $1,200,723 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $131,625 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $60,625 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $27,228 for the fair value of incentive shares earned by two wholesale dealers as of December 31, 2022 (see Note 4). There was a total of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220701__20230331__srt--CounterpartyNameAxis__custom--VariousGranteesMember_zRT6VgLR4cVi">384,759 shares of common stock that were issued to various grantees, including our two executive officers, in the nine months ended March 31, 2023, of which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220701__20230331__srt--CounterpartyNameAxis__custom--ExecutiveOfficersMember_zK0QKqBy9lS3">75,000 shares were previously expensed in the year ended June 30, 2022. In the nine months ended March 31, 2022, we recognized total non-cash stock compensation expense of $4,361,370 as follows: (i) $3,505,000 for the fair value of 500,000 incentive shares earned as of December 31, 2021 by a company controlled by the Company’s CEO under a previous compensation plan (which were not issued until early 2022); (ii) $<span id="xdx_901_eus-gaap--ShareBasedCompensation_pp0p0_c20210701__20220331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsGrantedMember_zGJdlwu8VOxl" title="Share-Based Payment Arrangement, Noncash Expense">193,314 for the initial amortized value of the RSUs granted to our two executive officers, as previously described; (iii) $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20210701__20220331__us-gaap--TransactionTypeAxis__custom--FairValueOfBonusSharesEarnedMember_pp0p0" title="Share-Based Payment Arrangement, Noncash Expense">175,250 for the fair value of 25,000 bonus shares earned as of December 31, 2021 by an outside attorney (which were not issued until early 2022); (iv) $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210701__20220331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedToAttorneyMember_pp0p0" title="Share-Based Payment Arrangement, Noncash Expense">236,619 for the amortized value of 50,000 shares granted to an attorney and a consultant pursuant to one year service agreements in mid 2021; (v) $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20210701__20220331__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesToNewIndependentDirectorMember_pp0p0" title="Share-Based Payment Arrangement, Noncash Expense">191,125 for the amortized value of 50,000 shares attributable to a new independent director in early 2021; and (vi) $<span id="xdx_909_eus-gaap--ShareBasedCompensation_pp0p0_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesWholesaleDealerMember_ztQwU5fou5R" title="Share-Based Payment Arrangement, Noncash Expense">60,062 for the fair value of 8,568 incentive shares earned by a wholesale dealer as of December 31, 2021 (see Note 4). There was a total of 1,237,733 shares of common stock that were issued to various grantees, primarily advisors, attorneys and consultants, in the nine months ended March 31, 2022. Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c20190228__us-gaap--PlanNameAxis__custom--StockOptionPlan2019Member_pdd" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized">2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of March 31, 2023, the Company has made awards totaling <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220701__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--TwoExecutivesMember_ztVe33TN1im8" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period">450,000 shares for the RSUs granted to two executives, as noted above, under the Plan.

4.00

1121250

4.00

4485000

3780000

58500

4.40

59251

9404867

1068000

267000

6922

1098630

1179750

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zWb0QV7nNGs2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Schedule of warrants activity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Wtd. Avg.</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Exercise</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Remaining</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at July 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20220701__20230331_zVXNft8hhKJg" style="text-align: right" title="Class of Warrant or Right, Outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20220701__20230331_zvcDlSOIf07k" style="text-align: right" title="Class of Warrant or Right, Exercise Price of Warrants or Rights">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 32%; text-align: left">Warrants issued to Public Investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--WarrantsIssuedToPublicInvestors_c20220701__20230331_zKHxhnR2yK01" style="width: 13%; text-align: right" title="Warrants issued to public investors">1,121,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--WarrantIssuedToPublicInvestorsWeightedAverageExcercisePrice_c20220701__20230331_zdyV4W0ij3Mi" style="width: 13%; text-align: right" title="Warrant issued to public investors, weighted average excercise price">4.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants issued to Underwriters</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_ecustom--WarrantsIssuedToUnderwriters_c20220701__20230331_zXykRyhw35uc" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants issued to underwriters">58,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--WarrantIssuedToUnderwritersWeightedAverageExcercisePrice_c20220701__20230331_zXLAjRGMtJkk" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant issued to underwriters, weighted average excercise price">4.40</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20220701__20230331_z301vhi9Jt85" style="border-bottom: Black 2.5pt double; text-align: right" title="Class of Warrant or Right, Outstanding">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20220701__20230331_zRFCPXZmA0Qi" style="border-bottom: Black 2.5pt double; text-align: right" title="Class of Warrant or Right, Exercise Price of Warrants or Rights">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_d0_c20230331_zt2PETFiHOKg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate intrinsic value, outstanding">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_982_ecustom--WarrantsExercisableShares_c20230331_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable, shares">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--WarrantsExercisableWeightedAverageExercisePrice_c20230331_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable, weighted average exercise price">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4.3</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_pp0p0_d0_c20230331_z6eQUNaa9mki" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant exercisable, aggregate intrinsic value">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

1121250 4.00 58500 4.40

1179750

4.02

P4Y3M18D

1179750 4.02 P4Y3M18D 0

146250

26000

97500

1420201

1200723

131625

60625

27228

384759

75000

4361370

3505000

193314

175250

236619

191125

60062

2500000

450000

(4) Commitments and Contingencies Effective January 1, 2021, the Company secured new corporate and manufacturing office space under a sublease agreement with its contract manufacturer. Under the terms of the sublease agreement, the Company is required to make rental payments of $10,350 per month during the initial one-year term of the agreement. The sublease agreement is renewable upon mutual agreement of both parties for up to four additional years at a modest increase in the monthly rent, however, the Company is under no obligation to renew it. Management has determined that the exercise of the renewal option is not reasonably certain and, as such, the Company has accounted for it as a short-term lease under ASC 842, Leases. Effective January 1, 2023, the Company elected to renew the agreement for another one year period (see Note 5). As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums. From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

(5) Subsequent Events In April 2023, we amended the agreement with our contract manufacturer (see Note 4) to provide for the purchase by us of all of the contract manufacturer’s existing inventory used to assemble our ESS units and to also provide for the eventual assumption by us of full responsibility for the manufacturing of our ESS units. Pursuant to the amended agreement, we completed the purchase of our contract manufacturer’s assembly inventory by making a cash payment of $1.3 million to this company and have now recorded such purchased inventory on our balance sheet. We presently expect to assume full responsibility for the manufacturing process surrounding our ESS units from the contract manufacturer by June 1, 2023. All of our manufacturing certifications are listed under NeoVolta. This amended agreement has no effect on the present sublease agreement with our contract manufacturer.

EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 98 153 1 false 35 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neovolta.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://neovolta.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/BalanceSheetsParenthetical Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://neovolta.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/StatementsOfOperationsParenthetical Statements of Operations (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) Sheet http://neovolta.com/role/StatementsOfStockholdersEquity Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Statements of Cash Flows (Unaudited) Sheet http://neovolta.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Business and Summary of Significant Accounting Policies Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies Business and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Notes Payable Notes http://neovolta.com/role/NotesPayable Notes Payable Notes 9 false false R10.htm 00000010 - Disclosure - Equity Sheet http://neovolta.com/role/Equity Equity Notes 10 false false R11.htm 00000011 - Disclosure - Commitments and Contingencies Sheet http://neovolta.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 00000012 - Disclosure - Subsequent Events Sheet http://neovolta.com/role/SubsequentEvents Subsequent Events Notes 12 false false R13.htm 00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies Business and Summary of Significant Accounting Policies (Policies) Policies http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 13 false false R14.htm 00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables Business and Summary of Significant Accounting Policies (Tables) Tables http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Equity (Tables) Sheet http://neovolta.com/role/EquityTables Equity (Tables) Tables http://neovolta.com/role/Equity 15 false false R16.htm 00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory Business and Summary of Significant Accounting Policies (Details Inventory) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 16 false false R17.htm 00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Business and Summary of Significant Accounting Policies (Details Narrative) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 17 false false R18.htm 00000018 - Disclosure - Notes Payable (Details Narrative) Notes http://neovolta.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://neovolta.com/role/NotesPayable 18 false false R19.htm 00000019 - Disclosure - Equity (Details - Warrant activity) Sheet http://neovolta.com/role/EquityDetails-WarrantActivity Equity (Details - Warrant activity) Details http://neovolta.com/role/EquityTables 19 false false R20.htm 00000020 - Disclosure - Equity (Details Narrative) Sheet http://neovolta.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://neovolta.com/role/EquityTables 20 false false All Reports Book All Reports neovolta_i10q-033123.htm neov-20230331.xsd neov-20230331_cal.xml neov-20230331_def.xml neov-20230331_lab.xml neov-20230331_pre.xml neovolta_ex3101.htm neovolta_ex3102.htm neovolta_ex3201.htm neovolta_ex3202.htm image_001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 38 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "neovolta_i10q-033123.htm": { "axisCustom": 0, "axisStandard": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 338, "http://xbrl.sec.gov/dei/2023": 34 }, "contextCount": 98, "dts": { "calculationLink": { "local": [ "neov-20230331_cal.xml" ] }, "definitionLink": { "local": [ "neov-20230331_def.xml" ] }, "inline": { "local": [ "neovolta_i10q-033123.htm" ] }, "labelLink": { "local": [ "neov-20230331_lab.xml" ] }, "presentationLink": { "local": [ "neov-20230331_pre.xml" ] }, "schema": { "local": [ "neov-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 271, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 26, "http://neovolta.com/20230331": 1, "http://xbrl.sec.gov/dei/2023": 5, "total": 32 }, "keyCustom": 14, "keyStandard": 139, "memberCustom": 23, "memberStandard": 11, "nsprefix": "NEOV", "nsuri": "http://neovolta.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://neovolta.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Equity", "menuCat": "Notes", "order": "10", "role": "http://neovolta.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "11", "role": "http://neovolta.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "12", "role": "http://neovolta.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "13", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Business and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "14", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Business and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "15", "role": "http://neovolta.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)", "menuCat": "Details", "order": "16", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory", "shortName": "Business and Summary of Significant Accounting Policies (Details Inventory)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "17", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Business and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-08-012022-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConversionOfStockAmountConverted1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Notes Payable (Details Narrative)", "menuCat": "Details", "order": "18", "role": "http://neovolta.com/role/NotesPayableDetailsNarrative", "shortName": "Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Equity (Details - Warrant activity)", "menuCat": "Details", "order": "19", "role": "http://neovolta.com/role/EquityDetails-WarrantActivity", "shortName": "Equity (Details - Warrant activity)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://neovolta.com/role/BalanceSheets", "shortName": "Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Equity (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://neovolta.com/role/EquityDetailsNarrative", "shortName": "Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://neovolta.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://neovolta.com/role/StatementsOfOperations", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://neovolta.com/role/StatementsOfOperationsParenthetical", "shortName": "Statements of Operations (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2023-01-012023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Statements of Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://neovolta.com/role/StatementsOfStockholdersEquity", "shortName": "Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_CommonStockMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "7", "role": "http://neovolta.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Business and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies", "shortName": "Business and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Notes Payable", "menuCat": "Notes", "order": "9", "role": "http://neovolta.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-033123.htm", "contextRef": "From2022-07-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 35, "tag": { "NEOV_AdjustmentForChangeInAccountingPrinciple": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjustment for change in accounting principle" } } }, "localname": "AdjustmentForChangeInAccountingPrinciple", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "NEOV_AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjustment of debt discount related to adoption of new accounting principle" } } }, "localname": "AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NEOV_AmortizedValueOfNewCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of New Compensation Plan [Member]" } } }, "localname": "AmortizedValueOfNewCompensationPlanMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfRSUsGrantedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value of RSUs Granted [Member]" } } }, "localname": "AmortizedValueOfRSUsGrantedMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesGrantedToAttorneyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares Granted To Attorney [Member]" } } }, "localname": "AmortizedValueOfSharesGrantedToAttorneyMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesGrantedToVariousAdvisorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares Granted To Various Advisors [Member]" } } }, "localname": "AmortizedValueOfSharesGrantedToVariousAdvisorsMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesToNewIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares To New Independent Director [Member]" } } }, "localname": "AmortizedValueOfSharesToNewIndependentDirectorMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_CommonStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "localname": "CommonStockParValue0.001PerShareMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "NEOV_ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion of convertible debt and accrued interest into common stock" } } }, "localname": "ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NEOV_ConvertibleDebt1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt 1 [Member]" } } }, "localname": "ConvertibleDebt1Member", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_ExecutiveOfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Executive Officers [Member]" } } }, "localname": "ExecutiveOfficersMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_FairValueOfBonusSharesEarnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Bonus Shares Earned [Member]" } } }, "localname": "FairValueOfBonusSharesEarnedMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_FairValueOfIncentiveSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares [Member]" } } }, "localname": "FairValueOfIncentiveSharesMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_FairValueOfIncentiveSharesWholesaleDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares Wholesale Dealer [Member]" } } }, "localname": "FairValueOfIncentiveSharesWholesaleDealerMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_InterimFinancialInformationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Financial Information" } } }, "localname": "InterimFinancialInformationPolicyTextBlock", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_OneDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Dealer [Member]" } } }, "localname": "OneDealerMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_PublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Offering [Member]" } } }, "localname": "PublicOfferingMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrant exercisable, aggregate intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "monetaryItemType" }, "NEOV_StockOptionPlan2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2019 Stock Option Plan [Member]" } } }, "localname": "StockOptionPlan2019Member", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThreeDealersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Dealers [Member]" } } }, "localname": "ThreeDealersMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThreeIndependentDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Independent Directors [Member]" } } }, "localname": "ThreeIndependentDirectorsMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThridDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thrid Dealer [Member]" } } }, "localname": "ThridDealerMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_TwoDealersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Dealers [Member]" } } }, "localname": "TwoDealersMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_TwoExecutivesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Executives [Member]" } } }, "localname": "TwoExecutivesMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_VariousGranteesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Various Grantees [Member]" } } }, "localname": "VariousGranteesMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_WarrantIssuedToPublicInvestorsWeightedAverageExcercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant issued to public investors, weighted average excercise price" } } }, "localname": "WarrantIssuedToPublicInvestorsWeightedAverageExcercisePrice", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "perShareItemType" }, "NEOV_WarrantIssuedToUnderwritersWeightedAverageExcercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant issued to underwriters, weighted average excercise price" } } }, "localname": "WarrantIssuedToUnderwritersWeightedAverageExcercisePrice", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "perShareItemType" }, "NEOV_WarrantsAndRightsOutstandingTermExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants term, exercisable" } } }, "localname": "WarrantsAndRightsOutstandingTermExercisable", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "durationItemType" }, "NEOV_WarrantsEachWarrantExercisableForOneShareOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants, each warrant exercisable for one share of common stock" } } }, "localname": "WarrantsEachWarrantExercisableForOneShareOfCommonStockMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "NEOV_WarrantsExercisableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercisable, shares" } } }, "localname": "WarrantsExercisableShares", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "NEOV_WarrantsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable, weighted average exercise price" } } }, "localname": "WarrantsExercisableWeightedAverageExercisePrice", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "perShareItemType" }, "NEOV_WarrantsIssuedToPublicInvestors": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to public investors" } } }, "localname": "WarrantsIssuedToPublicInvestors", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "NEOV_WarrantsIssuedToUnderwriters": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants issued to underwriters" } } }, "localname": "WarrantsIssuedToUnderwriters", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "NEOV_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_WarrantsUnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Underwriters [Member]" } } }, "localname": "WarrantsUnderwritersMember", "nsuri": "http://neovolta.com/20230331", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r457", "r459", "r460" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r125", "r126", "r197", "r223", "r313", "r417", "r419" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r168", "r430", "r486", "r520", "r521" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r168", "r430", "r486", "r520", "r521" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r125", "r126", "r197", "r223", "r313", "r418", "r419" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r7", "r434" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r53", "r434", "r523" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r273", "r274", "r275", "r342", "r478", "r479", "r480", "r513", "r525" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operations:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r103", "r171", "r175", "r176", "r178", "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r82", "r99", "r124", "r154", "r160", "r164", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r287", "r291", "r303", "r320", "r374", "r434", "r445", "r484", "r485", "r516" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r95", "r106", "r124", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r287", "r291", "r303", "r434", "r484", "r485", "r516" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r17", "r98", "r415" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r17", "r66", "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r0", "r66" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC uninsured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental non-cash financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r92", "r100", "r101", "r102", "r124", "r143", "r144", "r146", "r148", "r152", "r153", "r172", "r184", "r186", "r187", "r188", "r191", "r192", "r221", "r222", "r225", "r228", "r234", "r303", "r336", "r337", "r338", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r362", "r383", "r401", "r406", "r407", "r408", "r409", "r410", "r466", "r475", "r481" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price", "periodEndLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodStartLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Class of Warrant or Right, Outstanding", "periodStartLabel": "Class of Warrant or Right, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r13", "r46", "r321", "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 4)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r72", "r182", "r183", "r413", "r483" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r435", "r436", "r437", "r439", "r440", "r441", "r442", "r478", "r479", "r513", "r522", "r525" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r52", "r362" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r52", "r362", "r380", "r525", "r526" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r52", "r322", "r434" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 100,000,000 shares authorized, 33,155,127 and 21,977,251 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock Compensation Expense" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r25", "r27", "r40", "r41", "r168", "r412" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r25", "r27", "r40", "r41", "r168", "r333", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r25", "r27", "r40", "r41", "r168", "r412", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r25", "r27", "r40", "r41", "r168" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r25", "r27", "r40", "r41", "r168", "r412" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r20", "r21", "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "verboseLabel": "Amounts converted" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r20", "r21", "r22" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r74", "r194", "r195", "r205", "r206", "r207", "r211", "r212", "r213", "r214", "r215", "r425", "r426", "r427", "r428", "r429" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r12" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "verboseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r63", "r317" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r26", "r168" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r20", "r22" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r20", "r22" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Shares converted" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r73", "r122", "r193", "r199", "r200", "r201", "r202", "r203", "r204", "r209", "r216", "r217", "r219" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r75", "r196" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r11", "r195" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [ "r127", "r194", "r195", "r196", "r197", "r198", "r200", "r205", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r218", "r311", "r425", "r426", "r427", "r428", "r429", "r476" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r12", "r33", "r34", "r42", "r43", "r45", "r47", "r77", "r78", "r127", "r194", "r195", "r196", "r197", "r198", "r200", "r205", "r206", "r207", "r208", "r210", "r211", "r212", "r213", "r214", "r215", "r218", "r311", "r425", "r426", "r427", "r428", "r429", "r476" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Accrued compensation expenses" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r114", "r133", "r134", "r135", "r136", "r137", "r141", "r143", "r146", "r147", "r148", "r150", "r301", "r302", "r318", "r327", "r422" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r114", "r133", "r134", "r135", "r136", "r137", "r143", "r146", "r147", "r148", "r150", "r301", "r302", "r318", "r327", "r422" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r23", "r24" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r4", "r93", "r110", "r111", "r112", "r128", "r129", "r130", "r132", "r138", "r140", "r151", "r173", "r174", "r236", "r273", "r274", "r275", "r284", "r285", "r293", "r294", "r295", "r296", "r297", "r298", "r300", "r304", "r305", "r306", "r307", "r308", "r309", "r312", "r328", "r329", "r330", "r342", "r401" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r3", "r5" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r64", "r385" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r62", "r124", "r154", "r159", "r163", "r165", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r303", "r424", "r484" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r109", "r278", "r279", "r280", "r281", "r282", "r283", "r335" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidInsurance": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Insurance", "negatedLabel": "Prepaid insurance and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r44", "r85", "r113", "r157", "r310", "r386", "r443", "r524" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r116", "r119", "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r469" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r105", "r416", "r434" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r86", "r97", "r104", "r179", "r180", "r181", "r316", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r471" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r31", "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r470" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r8", "r124", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r288", "r291", "r292", "r303", "r360", "r423", "r445", "r484", "r516", "r517" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r57", "r83", "r324", "r434", "r477", "r482", "r515" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r10", "r96", "r124", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r288", "r291", "r292", "r303", "r434", "r484", "r516", "r517" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r12", "r32" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r118" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash flows provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r67", "r68" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r61", "r68", "r84", "r94", "r107", "r108", "r112", "r124", "r131", "r133", "r134", "r135", "r136", "r139", "r140", "r145", "r154", "r159", "r163", "r165", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r302", "r303", "r326", "r382", "r399", "r400", "r424", "r443", "r484" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r154", "r159", "r163", "r165", "r424" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r49", "r69", "r70", "r80" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Business and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r473" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid insurance and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r16" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible notes payable", "verboseLabel": "Proceeds from Convertible Debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r1" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Underwritten public offering of common stock", "verboseLabel": "Proceeds from Issuance Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r1", "r336" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r94", "r107", "r108", "r117", "r124", "r131", "r139", "r140", "r154", "r159", "r163", "r165", "r172", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r286", "r289", "r290", "r302", "r303", "r319", "r325", "r341", "r382", "r399", "r400", "r424", "r432", "r433", "r444", "r474", "r484" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r115", "r177" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r48", "r277", "r518" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r54", "r79", "r323", "r331", "r332", "r340", "r363", "r434" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r93", "r128", "r129", "r130", "r132", "r138", "r140", "r173", "r174", "r273", "r274", "r275", "r284", "r285", "r293", "r295", "r296", "r298", "r300", "r328", "r330", "r342", "r525" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r155", "r156", "r158", "r161", "r162", "r166", "r167", "r168", "r245", "r246", "r317" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenues from contracts with customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r91", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Allowance for Doubtful Accounts" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r384", "r414", "r421" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r168", "r467" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r6", "r58", "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of warrants activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesFinancingTransactionAxis": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.", "label": "Securities Financing Transaction [Axis]" } } }, "localname": "SecuritiesFinancingTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SecuritiesFinancingTransactionTypeDomain": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Measurement of financing transaction securities held." } } }, "localname": "SecuritiesFinancingTransactionTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r2" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of shares exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Aggregate intrinsic value, outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r92", "r100", "r101", "r102", "r124", "r143", "r144", "r146", "r148", "r152", "r153", "r172", "r184", "r186", "r187", "r188", "r191", "r192", "r221", "r222", "r225", "r228", "r234", "r303", "r336", "r337", "r338", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r362", "r383", "r401", "r406", "r407", "r408", "r409", "r410", "r466", "r475", "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r4", "r15", "r93", "r110", "r111", "r112", "r128", "r129", "r130", "r132", "r138", "r140", "r151", "r173", "r174", "r236", "r273", "r274", "r275", "r284", "r285", "r293", "r294", "r295", "r296", "r297", "r298", "r300", "r304", "r305", "r306", "r307", "r308", "r309", "r312", "r328", "r329", "r330", "r342", "r401" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r128", "r129", "r130", "r151", "r317", "r334", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r362", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r375", "r376", "r377", "r378", "r379", "r381", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r401", "r438" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r128", "r129", "r130", "r151", "r317", "r334", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r362", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r375", "r376", "r377", "r378", "r379", "r381", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r401", "r438" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r4", "r14", "r33", "r79", "r210" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Issuance of common stock for conversion of debt and accrued interest, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r4", "r51", "r52", "r79", "r336", "r401", "r407" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock in underwritten public offering, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r4", "r51", "r52", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock compensation expense, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r4", "r15", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Issuance of common stock for conversion of debt and accrued interest" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r4", "r51", "r52", "r79", "r342", "r401", "r407", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of common stock in underwritten public offering" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r38", "r51", "r52", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock compensation expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r52", "r55", "r56", "r71", "r364", "r380", "r402", "r403", "r434", "r445", "r477", "r482", "r515", "r525" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r76", "r123", "r220", "r222", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236", "r299", "r404", "r405", "r411" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r314", "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Liquidity" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r28", "r29", "r30", "r87", "r88", "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r435", "r436", "r439", "r440", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r142", "r148" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r141", "r148" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r447": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r448": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r449": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r453": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r454": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r455": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r456": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r457": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r458": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r459": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r461": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r462": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r463": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r464": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r465": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org//205-40/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 39 0001683168-23-003269-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-003269-xbrl.zip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�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